<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
and Rule 13a-17 or 15d-17 thereunder
NPS PHARMACEUTICALS, INC.
---------------------------------------------
(Exact name of issuer as specified in charter)
Delaware 0-23272 87-0439579
- ---------------------------- ------------------------ -------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
420 Chipeta Way
Salt Lake City, Utah 84108-1256
--------------------------------------
(Address of principal executive offices, including zip code)
(801) 583-4939
------------------------
(Issuer's telephone number, including area code)
<PAGE>
ITEM I. CHANGE IN NUMBER OF SHARES OUTSTANDING
1. Title of security: Common Stock
------------------------------------------------------
2. Number of Shares outstanding before the change: 8,187,232
------------------------
3. Number of Shares outstanding after the change: 11,637,232
------------------------
4. Effective date of change: May 8, 1996
-----------------------------------------------
5. Method of change: Sale to Underwriters and Underwriters' exercise of over-
--------------------------------------------------------
allotment option and public offering covered by Registration Statement on
---------------------------------------------------------------------------
Form S-1 (File No. 333-02566).
---------------------------------------------------------------------------
Dated: May 14, 1996
NPS PHARMACEUTICALS, INC.
By: /s/ Robert K. Merrell
------------------------------
Robert K. Merrell
Vice President, Finance,
Chief Financial Officer
and Treasurer
